Genetic profiling in radiotherapy: a comprehensive review
- PMID: 39132508
- PMCID: PMC11310144
- DOI: 10.3389/fonc.2024.1337815
Genetic profiling in radiotherapy: a comprehensive review
Abstract
This comprehensive review explores the pivotal role of radiotherapy in cancer treatment, emphasizing the diverse applications of genetic profiling. The review highlights genetic markers for predicting radiation toxicity, enabling personalized treatment planning. It delves into the impact of genetic profiling on radiotherapy strategies across various cancer types, discussing research findings related to treatment response, prognosis, and therapeutic resistance. The integration of genetic profiling is shown to transform cancer treatment paradigms, offering insights into personalized radiotherapy regimens and guiding decisions in cases where standard protocols may fall short. Ultimately, the review underscores the potential of genetic profiling to enhance patient outcomes and advance precision medicine in oncology.
Keywords: genomic profiling; profiling; radiation oncology (RO); radiogenomics; radiotherapy.
Copyright © 2024 Rubini, Gagliardi, Menditti, D’Ambrosio, Gallo, D’Onofrio, Pisani, Sardaro, Rubini, Cappabianca, Nardone and Reginelli.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
References
-
- Alaeikhanehshir S, Ajayi T, Duijnhoven FH, Poncet C, Olaniran RO, Lips EH, et al. . Locoregional breast cancer recurrence in the european organisation for research and treatment of cancer 10041/BIG 03-04 MINDACT trial: analysis of risk factors including the 70-gene signature. J Clin oncology: Off J Am Soc Clin Oncol. (2024) 10:Jco2202690. doi: 10.1200/JCO.22.02690 - DOI - PubMed
-
- Tramm T, Mohammed H, Myhre S, Kyndi M, Alsner J, Børresen-Dale AL, et al. . Development and validation of a gene profile predicting benefit of postmastectomy radiotherapy in patients with high-risk breast cancer: a study of gene expression in the DBCG82bc cohort. Clin Cancer research: an Off J Am Assoc Cancer Res. (2014) 20:5272–80. doi: 10.1158/1078-0432.CCR-14-0458 - DOI - PubMed
-
- Sjöström M, Chang SL, Fishbane N, Davicioni E, Zhao SG, Hartman L, et al. . Clinicogenomic radiotherapy classifier predicting the need for intensified locoregional treatment after breast-conserving surgery for early-stage breast cancer. J Clin oncology: Off J Am Soc Clin Oncol. (2019) 37:3340–9. doi: 10.1200/JCO.19.00761 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
